Study: Aspirin early on could be effective for COVID-19 patients

  • 📰 10News
  • ⏱ Reading Time:
  • 27 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 50%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Scientists from George Washington University looked at medical data of more than 110,000 U.S. patients from 64 hospitals.

Those with moderate symptoms, meaning not in the ICU or on a ventilator, who took aspirin in the first 24 hours, showed a lower risk of dying.

Chow says patients older than 60 and those with two or more underlying health conditions saw the most benefit. Aspirin is also cheap. It could help across the globe for people who can't afford or access other more expensive medicines like monoclonal antibodies. That includes Americans. "We had to cut the supply of monoclonal antibody treatments that we had distributed in the past to every state. That distribution to each state was reduced by 35%," Department of Health and Human Services Sec. Xavier Becerra said.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 732. in HEALTH

Health Health Latest News, Health Health Headlines